Updated Friday, February 22, 2008 0:00 am TWN, Reuters

U.S. company’s stem cells treat diabetes in mice

WASHINGTON -- Human stem cells transformed into nearly normal insulin-producing cells when implanted into mice, possibly offering a way to treat diabetes long-term, researchers at a U.S. company reported on Wednesday. The researchers used human embryonic stem cells — the most powerful but the most controversial source of stem cells.

Writing in the journal Nature Biotechnology, the team at San Diego, California-based Novocell Inc said their work showed that human embryonic stem cells might fulfill the promise of treating or perhaps even curing diabetes.

 

 

 

 

 

 

 

 

Subscribe to The China Post and save.  Click hereSharePrintEmail
Write a Comment



CAPTCHA Code Image
Change the code
 Receive China Post promos Respond to this email
Subscribe  |   Advertise  |   RSS Feed  |   About Us  |   Career  |   Contact Us
Sitemap  |   Top Stories  |   Taiwan  |   China  |   Business  |   Asia  |   World  |   Sports  |   Life  |   Arts & Leisure  |   Health  |   Editorial  |   Commentary
Travel  |   Movies  |   TV Guide  |   Classifieds  |   Bookstore  |   Getting Around  |   Weather  |   Guide Post  |   Student Post  |   English Courses  |   Terms of Use  |   Sitemap